Is Cabozantinib Really Better Than Sunitinib As First-Line Treatment of Metastatic Renal Cell Carcinoma? [electronic resource]
Producer: 20190523Description: 1858-1859 p. digitalISSN:- 1527-7755
No physical items for this record
Publication Type: Letter; Comment
There are no comments on this title.
Log in to your account to post a comment.